Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT) occurs in ~1 in 1000 births, but is frequently not recognized until birth of an affected infant. When this occurs a thorough serologic workup is required to then confirm a clinical diagnosis of FNAIT. This presentation will discuss clinical findings in infants with FNAIT and methods used in an optimum laboratory workup.  The lecture will also provide information helpful in determining the risk that any future pregnancies will be affected by FNAIT.  Recorded 03/06/19

Target Audience: This presentation is intended for physicians, laboratory scientists, nurses, genetics counselors and other members of the healthcare team involved in the care of infants with Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT) and their mothers

The goal of this activity is to provide medical news to physicians and other healthcare professionals in order to enhance patient care.

Level of instruction: Advanced

Faculty : Brian Curtis, PhD, D(ABMLI), MT(ASCP)SBB - Senior Medical Laboratory Director, Platelet and Neutrophil Immunology Laboratory, Versiti

 CE credits available.

Release Date: 04/08/2019